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In accordance with the finding of our in vivo experiments reported earlier [(1983) Biochim. Biophys. Acta 761,142-157; 
(1986) Biochim. Biophys. Acta 888, 184-190], the results of in vitro experiments show t at Kupffer cells avidly take up 
cholesterol-poor but not cholesterol-rich liposomes, whereas splenic phagocytic cells take up preferentially cholesterol- 
rich rather than cholesterol-poor liposomes in the presence ofse um. Evidence presented here suggests that s rum con- 
tains opsonins specific for hepatic and splenic phagocytic cells and these opsonins have different affinities for cholesterol- 
rich and cholesterol-poor liposomes. 
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1. INTRODUCTION 
Intravenously injected liposomes are rapidly se- 
questered by mononuclear phagocytes of  the 
reticuloendothelial system and liver and spleen are 
the major organs involved in the clearance of  
l iposomes from the circulation [1]. Inclusion of  
cholesterol in liposomes is known to increase their 
half-life in the bloodstream [2,3]. This is achieved 
by cholesterol playing a dual role [4], firstly, it 
stabilizes the l iposomal membrane and makes it 
less susceptible to destruction by various serum 
components [5,6]. Secondly it makes liposomes 
unfavourable for phagocytosis by hepatic Kupffer 
cells [4,7,8]. The reason why Kupffer cells have a 
poor affinity for cholesterol-rich liposomes is not 
yet known. Cholesterol influences the fluidity of  
l iposomal membranes and binding of  serum op- 
sonin(s) on liposomes [9-11] and may perhaps af- 
fect the uptake of  l iposomes by these cells. 
Furthermore, we reported earlier [7] that liver 
and spleen respond differently to cholesterol-free 
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and cholesterol-rich liposomes when injected to 
produce a reticuloendothelial blockade but the 
mechanism by which these organs handle the two 
types of  l iposomes differently is not known. Hence 
to investigate the possible mechanism responsible 
for the suppression of  cholesterol-rich l iposome 
uptake in liver and factors which stimulate a dif- 
ferential response in hepatic and splenic 
phagocytic activity, we have studied the uptake of  
l iposomes in the absence and presence of  rat serum 
by using the isolated hepatic and splenic cells in 
suspension. 
2. MATERIALS  AND METHODS 
Negatively charged multilamellar liposomes containing 1251- 
labelled poly(vinylpyrrolidone) were prepared as described 
earlier [4,7] from a mixture of phosphatidylcholine/ 
cholesterol/dicetylphosphate in a molar ratio 7:7:1 for 
cholesterol-rich, 7:2:1 for cholesterol-poor and 7:0:1 for 
cholesterol-free liposomes, respectively. Thus the c olesterol 
content of cholesterol-rich liposomes was 46.6 molo70, for 
cholesterol-poor 20 molo70 and for cholesterol-free 0 tool%. 
Cholesterol and dicetylphosphate were purchased from 
Sigma (England), phosphatidylcholine from Lipid Products 
(England) and 125I-labelled poly(vinylpyrrolidone) from Amer- 
sham. Liposomes (15mg) were opsonised by incubation i  50o70 
fresh rat serum (diluted with saline) for 15 min at 37°C, follow- 
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ed by centrifugation at 200000 x g for 30 min to pellet the op- 
sonised liposomes. In some experiments he pellet was washed 
once with saline and centrifuged to obtain a liposome pellet as 
described above. 
Hepatic non-parenchymal cells, containing predominantly 
endothelial and Kupffer cells, and splenic white cells were 
prepared from CFY rats of body weight 250 _+ 25 g by methods 
described by Doolittle and Richter [12] and Kleiman et al. [13], 
respectively. 
Splenic cells (=--8 x 107 cells) were incubated in polythene 
vials at 37°C for l h with liposomes (=--0.6 mg lipid) in the 
absence and presence of 25070 fresh rat serum in a total volume 
adjusted to 2.0 ml with 10 mM oxygenated phosphate-saline 
buffer, pH 7.4 containing 5.0 mM glucose and 1070 bovine 
serum albumin. The incubation media for hepatic cells 
(~ X 107) was the same as that described for the splenic ells ex- 
cept that phosphate-saline buffer was replaced with 
CaE+/Mg2÷-free Hanks' balanced salt solution (Gibco). The 
uptake of ~25I-labelled poly(vinylpyrrolidone) radioactivity was 
measured in the cells at the end of the incubation [14]. Each in- 
cubation was performed in duplicate and each experiment was 
repeated more than twice and since opsonic activity varies from 
day to day and animal to animal the results of a typical experi- 
ment expressed as mean (of duplicate incubations) percentage 
of the total ~251-radioactivity nitially added to each incubation 
are presented. Since free ~25I-labelled poly(vinylpyrrolidone) is 
not degradable and not adsorbed onto or taken up by cells, the 
radioactivity associated with cells indicates the presence of in- 
tact liposomes [7,15]. In our experiments, the uptake of 
liposomes in the absence of serum was suppressed by 40-50°70 
by substances known to inhibit endocytosis [16]. 
3. RESULTS 
The results in fig.la show that hepatic and 
splenic cells take up cholesterol-free liposomes 
much more than cholesterol-containing liposomes 
in the absence of serum. Serum suppressed the up- 
take of cholesterol-free liposomes by both hepatic 
and splenic ceils (fig. lb). This may be attributed to 
the fact that cholesterol-free liposomes are degrad- 
ed in serum [2-6], as a consequence a smaller 
number of intact liposomes may be available to 
cells for phagocytosis which may apparently result 
in the poor uptake [4]. Among cholesterol- 
containing liposomes, cholesterol-poor a e taken 
up much more by hepatic and splenic cells in the 
absence of serum than cholesterol-rich liposomes. 
Serum enhances the uptake of cholesterol-poor by
hepatic ells but suppresses that of cholesterol-rich 
liposomes, in comparison to the results obtained in 
the absence of serum. In contrast, serum 
stimulates uptake of cholesterol-containing 
liposomes by splenic cells (fig. la,b) but its opsonic 
effect is greater on the uptake of cholesterol-rich 
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Fig.l. Uptake of liposomes by liver and spleen cells in the 
absence (a) and presence (b) of rat serum. Cholesterol-free 
(~) ,  cholesterol-poor (~. ,) and cholesterol-rich (~_\\-~). For 
experimental details see section 2. 
than cholesterol-poor liposomes, since cholesterol- 
rich liposomes are taken up twice as much as 
cholesterol-poor by splenic cells. 
The negatively charged liposomes used here have 
been shown to be endocytosed rapidly by Kupffer 
cells [171, and endothelial cells present in our 
hepatic cell preparation do not take up liposomes 
[15]. Since the main mechanism of interaction of 
liposomes with Kupffer cells in vitro is adsorptive 
endocytosis [18], we examined the effect of 
cholesterol and serum on adsorption of liposomes 
at 4°C. At this temperature liposomes are 
predominantly adsorbed onto the cell surface and 
not phagocytosed [18]. It was found (see table 1) 
that the presence of cholesterol in liposomes 
reduces adsorption and serum further hinders this 
process for all liposomes in hepatic and splenic 
cells except the adsorption of cholesterol-rich 
liposomes on splenic ceils which, in contrast, is 
enhanced. The total amount of all liposomes ad- 
sorbed on the cells did not constitute more than a 
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Table 1 
Adsorption of liposomes onto liver and spleen cells at 4°C 
Adsorption (% of initial [125I]-PVP 
radioactivity) a 
Chol-free Chol-poor Chol-rich Liposomes: 
Serum: - + - + - + 
Liver cells 4.50 3.80 0.90 0.27 0.16 0.19 
Spleen cells 1.60 0.67 0.17 0.13 0.23 0.99 
a Mean of duplicate incubations 
For experimental details ee section 2. These experiments were 
done twice and the results of a typical experiment are presented 
few per cent of  total  l iposomes taken up by the 
cells at 37°C, except in the case of  cholesterol-free 
l iposomes in hepatic cells where the results of  ab- 
sorpt ion at 4°C and uptake at 37°C (fig. lb)  in the 
presence of  serum are similar. This makes it dif-  
f icult to assess the role of  serum on the uptake of  
cholesterol-free l iposomes by these cells and hence 
in our subsequent studies cholesterol-free 
l iposomes were omitted.  
The effect of  serum on uptake o f  l iposomes is 
further conf i rmed when opsonised cholesterol-  
poor  and cholesterol-r ich l iposomes were in- 
cubated with hepatic and splenic cells at 37°C. The 
results in table 2 show that opsonisat ion enhances 
uptake of  cholesterol -poor but suppresses that of  
cholesterol-r ich l iposomes by liver cells. When op- 
sonised cholesterol -poor vesicles were washed once 
with saline pr ior  to the incubat ion with liver cells, 
the opsonic effect was lost. 
On the other hand,  a l though serum enhances up- 
take o f  both cholesterol -poor  and cholesterol-r ich 
l iposomes in splenic cells, opsonisat ion of  
cholesterol -poor l iposomes has no opsonic effect 
on their uptake by these cells. However,  opsonised 
cholesterol-r ich l iposomes are taken up 2-fold 
more than unopsonised control  l iposomes, but this 
represents only 12°70 of  the total  l iposomes taken 
up by splenic cells in the presence of  serum. This 
small opsonic activity o f  the opsonised cholesterol-  
rich l iposomes is not lost when l iposomes were 
washed prior to the incubat ion with cells. 
E lectrophoret ic  studies o f  the opsonised 
cholesterol -poor  and cholesterol-r ich l iposomes 
Table 2 
Uptake of opsonized liposomes by liver and spleen cells 
Treatment Uptake (% of initial 
[~zsI]-PVP radioactivity) a 
Liver cells Spleen cells 
Chol-poor liposomes 
Liposomes (control) 7.6 5.3 
Liposomes + serum 22.7 9.1 
Opsonized liposomes 15.4 5.3 
Washed opsonized liposomes 7.2 ND 
Chol-rich liposomes 
Liposomes (control) 5.0 1.6 
Liposomes + serum 2.1 31.7 
Opsonized liposomes 2.8 3.8 
Washed opsonized liposomes ND 3.1 
a Mean of duplicate incubations 
ND, not done. For experimental details ee section 2. The whole 
experiment was repeated three times and only the results of a 
typical experiment are presented here 
Fig.2. SDS-PAGE electrophoresis of opsonized cholesterol 
containing liposomes by Pharmacia Phast-Electrophoresis 
system on a 10-15% gradient gel. Direction of migration is 
from bottom to the top. A, Serum; B, opsonized cholesterol- 
rich liposomes; C, washed opsonized cholesterol-rich 
liposomes; D, opsonized cholesterol-poor liposomes; E, washed 
opsonized cholesterol-poor liposomes; F, standards (from 
bottom to top: phosphorylase a, bovine albumin, ovalbumin 
and cytochrome c). 
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show that more serum proteins are associated with 
cholesterol-poor liposomes than cholesterol-rich 
liposomes (fig.2). This may be attributed to the in- 
creased rigidity of the membrane due to a high 
concentration of cholesterol (-----46.6 mol%) in 
cholesterol-rich liposomes [9]. Washing opsonised 
liposomes with saline removes most of the serum 
proteins associated on both cholesterol-poor and 
cholesterol-rich opsonised liposomes and the pro- 
teins retained give very similar bands on gels in 
both preparations. 
4. DISCUSSION 
The results presented here confirm our earlier 
findings of in vivo studies [4,7] and show that 
Kupffer cells take up avidly cholesterol-poor but 
not cholesterol-rich liposomes, whereas splenic 
cells take up preferentially cholesterol-rich more 
than cholesterol-poor liposomes in the presence of 
serum. The experiments with opsonised liposomes 
(table 2) suggest that there are opsonins present in 
serum which are specific for liver and spleen 
phagocytes. Opsonin(s) specific for liver cells have 
no affinity for cholesterol-rich liposomes since no 
enhancement in uptake of these liposomes is 
observed either in the presence of serum (fig. 1) or 
when liposomes are pre-opsonised with serum. 
This opsonin exerts its action probably on liver 
phagocytic cells by being adsorbed loosely on the 
surface of cholesterol-poor liposomes, since when 
the opsonised liposomes are washed prior to in- 
cubation with these cells, its opsonic effect is lost. 
Cholesterol (-~ 46.6 mol%) incorporated in 
cholesterol-rich liposomes decreases the fluidity of 
their membrane [19] and this could interfere with 
the interaction f liposomes with Kupffer cells, 
since it is known that the fluidity of membrane 
determines the ability of liposomes to interact with 
cells [11,20]. Our results also indicate that certain 
serum components hinder the absorption and 
eventually uptake of liposomes by Kupffer cells. 
However, the most likely explanation for the poor 
uptake of cholesterol-rich liposomes by Kupffer 
cells is that cholesterol has been shown to reduce 
the interaction of liposomes with serum proteins 
(see [10] and fig.2) and serum components [5,6], it 
is therefore not surprising that incorporation of 
46.6 mol% cholesterol in these liposomes renders 
them less attractive for the interaction with liver 
specific opsonin and hence no stimulant for Kupf- 
fer cells. 
On the other hand, the opsonin(s) specific for 
splenic cells stimulate phagocytosis of both 
preparations of cholesterol-containing liposomes 
but its effect is greater on the uptake of the rigid 
cholesterol-rich liposomes. However, unlike the 
opsonin specific for liver cells, this factor(s) does 
not exert its effect on splenic phagocytes by being 
adsorbed on the surface of liposomes, since no 
enhancement i  uptake of the opsonised liposomes 
is observed (table 2). This probably suggests that, 
unlike in the case of liver, this opsonin may exert 
its effect by binding to the site other than the 
liposome-binding site on the spleen cell surface. 
However, since a small increase in uptake of the 
opsonised cholesterol-rich liposomes is found 
(table 2), it may indicate that more than one opo 
sonin specific for spleen cells may be present in 
serum. Among these opsonins, one probably binds 
tightly to cholesterol-rich liposomes and enhances 
their uptake to a smaller extent han that observed 
in the presence of serum. It is also possible that this 
opsonin may also act on cells like lymphocytes in
spleen cell preparations, which may be stimulated 
to take up liposomes [7]. 
The results discussed here probably explain why 
early attempts o show the opsonic effect of serum 
on phagocytosis of liposomes by Kupffer cells in 
vivo [21,22] and in vitro [18] were not successful. 
These investigators u ed cholesterol-rich liposomes 
(----50 mol°70 cholesterol content) and sometimes 
they used phospholipids other than phosphatidyl- 
choline [19]. Our experimental d ta (manuscript in
preparation) suggest hat like cholesterol, certain 
phospholipids have a poor affinity for opsonin 
specific for liver and hence their uptake in liver and 
consequently distribution in the whole body is 
altered. The chemical nature of the opsonins 
specific for both liver and spleen cells is not 
known, but experiments are in progress to charac- 
terise some of their properties in order to evaluate 
their role in various diseases and their potential in 
targetting drug carriers to phagocytic ells of 
specific organs of the reticuloendothelial system. 
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